As we evaluated the high levels of LOX that partially contributed to increased collagen-containing fibrils and the stiffness in the MDA-MB-231 tumors, we next added tumor lysates prepared from the respective tumor tissues to the LS-AuNPs to determine whether the LS-AuNPs could sensitively detect the LOX levels in the tumor microenvironment. This evidence concerns the gene LOX and neoplasm.